Julia Eismann

424 citations
6 papers · 107 indexed · h-index 5
Topics
PARP inhibition in cancer therapy (2 papers)RNA modifications and cancer (1 paper)Salmonella and Campylobacter epidemiology (1 paper)

In The Last Decade

Julia Eismann

6 papers receiving 106 citations

Peers

Julia Eismann
Comparison fields: 5 of 39
  • Molecular Biology 33
  • Public Health, Environmental and Occupational Health 31
  • Genetics 30
  • Oncology 29
  • Cancer Research 29
Replace Margaret Akinhanmi with:
Margaret Akinhanmi United States
Maira Kentwell Australia
Doris Fadoju United States
Zulfa Omer United States
Manqi Chen China
Rosie O’Shea Australia
Davide Dalu Italy
Samuel N. Doernberg United States
Caitlin Mauer United States
Yasmin Bylstra Singapore
Julia Eismann relative to Margaret Akinhanmi United States Margaret Akinhanmi's profile →
Citations per field
00.5×3.9×
Margaret Akinhanmi · 1×
Citations per year

Countries citing papers authored by Julia Eismann

Since Specialization
Citations

This map shows the geographic impact of Julia Eismann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Julia Eismann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Julia Eismann more than expected).

Fields of papers citing papers by Julia Eismann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Julia Eismann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Julia Eismann. The network helps show where Julia Eismann may publish in the future.

Co-authorship network of co-authors of Julia Eismann

This figure shows the co-authorship network connecting the top 25 collaborators of Julia Eismann. A scholar is included among the top collaborators of Julia Eismann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Julia Eismann. Julia Eismann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

6 of 6 papers shown
#WorkIndexed citations
1 2
2 17
3 23
4 4
5 44
6 17

About Julia Eismann

Julia Eismann is a scholar working on Molecular Medicine, Endocrinology and Oncology, having authored 6 papers that have together received 107 indexed citations. Recurring topics across this work include PARP inhibition in cancer therapy (2 papers), RNA modifications and cancer (1 paper) and Salmonella and Campylobacter epidemiology (1 paper). The work is most often cited by research in Cancer Research (29 citations), Social Psychology (24 citations) and Genetics (30 citations). Julia Eismann has collaborated with scholars based in Germany, United States and France. Frequent co-authors include Gerburg M. Wulf, Yujing J. Heng, Adam M. Tobias, Jordana Phillips, Kari J. Kansal, Sheida Nabavi, Ursula A. Matulonis, Ewa Przybytkowski, Thomas A. Davis and Abdelrahman Hosny. Their work appears in journals such as International Journal of Environmental Research and Public Health, BMC Cancer and Oncology Reports.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026